Select Publications
Conference Abstracts
, 2025, 'Association Between Age of First Methamphetamine Use and Childhood Attention Deficit Hyperactivity Disorder Symptomatology—An Exploratory Study in a Clinical Trial Cohort', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Digital Health Interventions for People Who Use Methamphetamine: A Scoping Review', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Evidence-Based Practice in the Australian Alcohol and Other Drug Workforce: A Cross-Sectional Survey', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'A Pilot Study of the Safety and Feasibility of Oral Naltrexone and Bupropion for Methamphetamine Use Disorder', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Acceptability of Oral Naltrexone and Bupropion for Treatment of Methamphetamine Use Disorder', Sydney, presented at APSAD 2025 Conference, Sydney, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Australia’s First Trial of Supervised Injectable Opioid Injection Treatment With Hydromorphone for People With Opioid Use Disorder: First Findings', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Daily Smartphone Assessments for Substance Use Measurement in a Methamphetamine Clinical Trial', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'High-Dose MDMA Alerts at 150 Mg: Exploring the Utility and Appropriateness of Alert Thresholds', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'High-Dose MDMA Pills, Heroin-Adulterated Stimulants and Nitazene Detections the Most Common Concerns; Reporting on Drug Alerts Issued in Australia for 2024', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Identifying Concerns and Collaborating for Rapid Response; Preliminary Findings From the Formative Evaluation of the Prompt Response Network', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Learnings From the Implementation of a Consumer Advisory Group for a Nation-Wide Randomised Placebo-Controlled Clinical Trial Investigating a Pharmacotherapy for Methamphetamine Withdrawal', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'Managing Gamma-Hydroxybutyrate Withdrawal With Early Baclofen Loading: A Retrospective Case Series', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'People Seeking Treatment for Methamphetamine Use Are Getting Older and Treatment Services Need to Adapt', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2025, 'The Effect of Amphetamine-Type Stimulant Use at Start of Treatment on Substance Use and Treatment Retention During Treatment Among Clients Enrolled in an Opioid Agonist Program', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014
, 2023, 'Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
, 2023, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
, 2023, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: Recruitment to a novel safety and feasibility trial', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749
, 2023, 'OBJECTIVE AND SUBJECTIVE SLEEP DURING LISDEXAMFETAMINE TREATMENT OF ACUTE METHAMPHETAMINE WITHDRAWAL: NEW MEASUREMENT PARADIGM', in DRUG AND ALCOHOL DEPENDENCE, ELSEVIER IRELAND LTD, CO, Denver, Vol. 260, presented at 85th Annual Scientific Meeting of the College-on-Problems-of-Drug-Dependence (CPDD), CO, Denver, 17 July 2023 - 21 July 2023, http://dx.doi.org/10.1016/j.drugalcdep.2023.110067
, 2022, '"Sometimes I have a duty of care not to call 000": Reported practices, attitudes and factors influencing consumer responses to GHB overdose', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'An Australian national Prompt Response Network for emerging drugs', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S73 - S73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Strengthening first-line support for Australians who use drugs, their friends and families: A training needs analysis for alcohol and other drug helplines for calls relating to methamphetamine and emerging drugs of concern', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'The AusMAP study: A protocol for a randomised, controlled feasibility study of a managed alcohol program in Australia', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S44 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209
, 2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82
, 2019, 'A rapid clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern in Australia', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'Are we detoxing the right people, in the right setting and in the right way? A rapid review of the literature on withdrawal management', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'Optimising care for people who inject drugs: A retrospective medical record review of staphylococcus aureus bactaraemia treatment', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'What's in an app? Incorporating an automated consent procedure to recruit those who use methamphetamine to a harm reduction and early intervention smartphone-based application clinical trial', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991
, 2019, 'CHARACTERISTICS AND TREATMENT OUTCOMES OF THE DRUG TREATMENT POPULATION IN NEW SOUTH WALES: FOCUS ON AMPHETAMINE TYPE STIMULANTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'OPTIMISING CARE FOR PEOPLE WHO INJECT DRUGS: A RETROSPECTIVE MEDICAL RECORD REVIEW OF STAPHYLOCOCCUS AUREUS BACTERAEMIA TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Concomitant medication use in ART-experienced Australian adults: data from the PAART Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, NY, New York, Vol. 21, pp. A50 - A50, presented at 18th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV, NY, New York, 12 September 2016 - 13 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000389747500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1